SCNI

Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) | Rumor.io

Scinai Immunotherapeutics

SCNI

Attention (50-day avg)0%

Attention rank (50-day avg)#1,012

Bullish sentiment (50-day avg)87%

Price to earnings ratio0.05

Market capitalization996K

Earnings per share28.1

Dividend yield (TTM)—

Revenue (annual)1.3M

Net income (annual)-8.3M

Social

What share of all stock conversation is about SCNI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% +0	0% 0

Sep 23

The company's stock has been experiencing a green trend, with the price hitting $2.02, and the author feels alone in their HOD with only 8 followers.
The author believes that news is coming, and if management releases a positive announcement, the stock could break $5 and reach $10.
The company's 600k float and micro float bios are running, and the author thinks that a PR announcement could lead to significant gains, potentially exceeding 100%.

Generated by AI

Sentiment

Of the messages about SCNI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	95.97% +49.81	89.23% +7.98	90.78% +1.84
Bearish	—	4.03% -49.81	10.77% -7.98	9.22% -1.84

Bullish· Sep 23

The micro float of $600k is leading to significant gains, with previous bio PRs resulting in 100%+ gains in the current market.
The company's recent Nasdaq compliance news after a drop from $3 suggests that the stock may be due for a rebound.
A break above $2 could lead to a moonshot, with some investors predicting gains of $5-$10 if the company releases positive news and takes advantage of the low short interest.

Bearish· Sep 14

$SCNI has been experiencing a slow bleed with trading volume, which could be a sign of a decline in investor interest.
The company's shares are currently trading at a significantly lower price than expected, which may indicate a lack of trust in the company's fundamentals.
The asset's price has been unable to break through key resistance levels, with some analysts predicting a further decline if the price fails to move above $3.35.

Generated by AI

Topics

Of the messages about SCNI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	73.74%	77.44%
Technical Analysis	—	—	19.06%	19.15%
Analysts	—	—	3.6%	1.71%
Macro	—	—	3.6%	1.71%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0%

Announcements· May 15

NovaRed Mining's MetalCore platform has attracted around 249 onboarding applicants, indicating growing interest in the company beyond traditional mining investors.
The MetalCore platform is now tied to NovaRed Mining's 7 completed survey lines in BC, with geophysical targeting systems integrated into the system.
NovaRed Mining's Wilmac project has shown promising results, with copper anomalies at 1125 ppm and deeper porphyry targeting, making it more advanced than many early-stage projects.

Technical Analysis· Jun 17

Scinai Immunotherapeutics Ltd. ($SCNI) is forming a bull pennant, potentially setting up another short squeeze.
The stock has reclaimed its VWAP, indicating that bulls are in control as long as it stays above it, but VWAP is not a holy grail for trading decisions.
$SCNI has shown a 5-wave up pattern with volume, with possible extension targets at 8-8.50 and resistance at 7.20, 7.75, support at 6-5.90 and 5.60.

Generated by AI

Community

Of the messages about SCNI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	2.96%	14.45%	30.78%
Newcomers	100%	97.04%	85.55%	69.22%

Regulars· Sep 14

$SCNI is on watch for a potential breakout if it can break and base over VWAP in the 2.8s, with a range to $3.3/$5.00+.
The company's strategic refocus on the NanoAb platform and growing CDMO business is sparking interest, with some traders waiting for confirmation of a new high past $5.15.
$SCNI needs to hit $5+ before the open, and some traders are looking for a breakout to $9 and above.

Newcomers· Sep 23

Many users are focused on the potential for a $2 break in the SCNI stock price, with some predicting significant gains if this happens.
The micro float and bio activity in SCNI is being closely watched, with users believing that this could be a key indicator of the stock's performance.
Some users are speculating that the company's management may release positive news, such as a public relations announcement, which could take the stock to $5 or higher.

Generated by AI

News

Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company combining innovative immunology therapeutic development with a revenue-generating contract development and manufacturing organization ("CDMO"), today announced a strategic refocusing of its R&D portfolio following the conclusion of its option and license arrangements with PinCell S.r.l. relating to PC111.

22d agoYahoo Finance

Also Discussed

Investors talking about SCNI also mention

#	Name	Attention
1	Energy Services of America CorporationESOA	0%new
2	MFH - Mercurity Fintech Holding Inc.	——
3	Veea Inc.VEEA	0%0
4	VS Media Holdings Limited Class A Ordinary SharesVSME	0%+0
5	Netcapital Inc. Common StockNCPL	0.01%+0.01
6	SGE - Strong Global Entertainment, Inc.	——
7	SciSparc Ltd.SPRC	0%+0
8	Ainos, Inc.AIMD	0%+0
9	Thunder Power Holdings Inc.AIEV	0%0
10	Vision Marine Technologies Inc.VMAR	0%new

Scinai Immunotherapeutics Ltd. American Depositary Shares

Healthcare
Biotechnology

Scinai Immunotherapeutics Ltd. American Depositary Shares represent an ownership interest in a biopharmaceutical company focused on inflammation and immunology therapies. Scinai Immunotherapeutics develops biological products aimed at infectious and autoimmune diseases, including nanosized antibody programs and other immunology-focused candidates. The company also operates a contract development and manufacturing organization, providing development and manufacturing services for biotechnology clients from early-stage work through clinical production. Its business spans both internal research and development and third-party biomanufacturing, giving it a dual role in the life sciences market. Scinai Immunotherapeutics Ltd. is headquartered in Jerusalem, Israel, and its ADS structure allows investors to access the company through depositary shares rather than ordinary shares directly.

Website

Location

Jerusalem BioPark Building

Jerusalem

Israel

Social

What share of all stock conversation is about SCNI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% +0	0% 0

Sep 23

The company's stock has been experiencing a green trend, with the price hitting $2.02, and the author feels alone in their HOD with only 8 followers.
The author believes that news is coming, and if management releases a positive announcement, the stock could break $5 and reach $10.
The company's 600k float and micro float bios are running, and the author thinks that a PR announcement could lead to significant gains, potentially exceeding 100%.

Generated by AI

Sentiment

Of the messages about SCNI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	95.97% +49.81	89.23% +7.98	90.78% +1.84
Bearish	—	4.03% -49.81	10.77% -7.98	9.22% -1.84

Bullish· Sep 23

The micro float of $600k is leading to significant gains, with previous bio PRs resulting in 100%+ gains in the current market.
The company's recent Nasdaq compliance news after a drop from $3 suggests that the stock may be due for a rebound.
A break above $2 could lead to a moonshot, with some investors predicting gains of $5-$10 if the company releases positive news and takes advantage of the low short interest.

Bearish· Sep 14

$SCNI has been experiencing a slow bleed with trading volume, which could be a sign of a decline in investor interest.
The company's shares are currently trading at a significantly lower price than expected, which may indicate a lack of trust in the company's fundamentals.
The asset's price has been unable to break through key resistance levels, with some analysts predicting a further decline if the price fails to move above $3.35.

Generated by AI

Topics

Of the messages about SCNI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	73.74%	77.44%
Technical Analysis	—	—	19.06%	19.15%
Analysts	—	—	3.6%	1.71%
Macro	—	—	3.6%	1.71%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0%

Announcements· May 15

NovaRed Mining's MetalCore platform has attracted around 249 onboarding applicants, indicating growing interest in the company beyond traditional mining investors.
The MetalCore platform is now tied to NovaRed Mining's 7 completed survey lines in BC, with geophysical targeting systems integrated into the system.
NovaRed Mining's Wilmac project has shown promising results, with copper anomalies at 1125 ppm and deeper porphyry targeting, making it more advanced than many early-stage projects.

Technical Analysis· Jun 17

Scinai Immunotherapeutics Ltd. ($SCNI) is forming a bull pennant, potentially setting up another short squeeze.
The stock has reclaimed its VWAP, indicating that bulls are in control as long as it stays above it, but VWAP is not a holy grail for trading decisions.
$SCNI has shown a 5-wave up pattern with volume, with possible extension targets at 8-8.50 and resistance at 7.20, 7.75, support at 6-5.90 and 5.60.

Generated by AI

Community

Of the messages about SCNI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	2.96%	14.45%	30.78%
Newcomers	100%	97.04%	85.55%	69.22%

Regulars· Sep 14

$SCNI is on watch for a potential breakout if it can break and base over VWAP in the 2.8s, with a range to $3.3/$5.00+.
The company's strategic refocus on the NanoAb platform and growing CDMO business is sparking interest, with some traders waiting for confirmation of a new high past $5.15.
$SCNI needs to hit $5+ before the open, and some traders are looking for a breakout to $9 and above.

Newcomers· Sep 23

Many users are focused on the potential for a $2 break in the SCNI stock price, with some predicting significant gains if this happens.
The micro float and bio activity in SCNI is being closely watched, with users believing that this could be a key indicator of the stock's performance.
Some users are speculating that the company's management may release positive news, such as a public relations announcement, which could take the stock to $5 or higher.

Generated by AI

Scinai Immunotherapeutics

Social

Sep 23

Bullish· Sep 23

Bearish· Sep 14

Announcements· May 15

Technical Analysis· Jun 17

Regulars· Sep 14

Newcomers· Sep 23

Scinai regains compliance with Nasdaq minimum bid price rule

12 Health Care Stocks Moving In Monday's Intraday Session

Nasdaq Down Over 200 Points; Cellectis Shares Plunge

12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business

Also Discussed

Scinai Immunotherapeutics Ltd. American Depositary Shares

Company Information

Location

Scinai regains compliance with Nasdaq minimum bid price rule

12 Health Care Stocks Moving In Monday's Intraday Session

Nasdaq Down Over 200 Points; Cellectis Shares Plunge

12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business

Also Discussed

Social

Sep 23

Bullish· Sep 23

Bearish· Sep 14

Announcements· May 15

Technical Analysis· Jun 17

Regulars· Sep 14

Newcomers· Sep 23